We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
Cap. Flow
+$64.5M
Cap. Flow %
0.35%
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$285M
2
UNH icon
UnitedHealth
UNH
+$53.5M
3
GE icon
GE Aerospace
GE
+$36.4M
4
PEP icon
PepsiCo
PEP
+$12.5M
5
RL icon
Ralph Lauren
RL
+$10.1M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$39.4M
2
PM icon
Philip Morris
PM
+$20.6M
3
AAPL icon
Apple
AAPL
+$18.7M
4
KO icon
Coca-Cola
KO
+$17.7M
5
MO icon
Altria Group
MO
+$13.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.84%
2 Energy 18.16%
3 Financials 14.69%
4 Healthcare 10.53%
5 Technology 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
101
SLB Ltd
SLB
$72.7B
$7.27M 0.04%
76,899
-12,994
-14% -$1.03M
ANAT
102
DELISTED
American National Group, Inc. Common Stock
ANAT
$6.58M 0.04%
53,931
– –
AWH
103
DELISTED
Allied World Assurance Co Hld Lt
AWH
$6.35M 0.03%
157,020
– –
CDK
104
DELISTED
CDK Global, Inc.
CDK
$6.23M 0.03%
108,595
-330
-0.3% -$19K
MDT icon
105
Medtronic
MDT
$112B
$5.98M 0.03%
69,242
+600
+0.9% +$52.3K
BSM icon
106
Black Stone Minerals
BSM
$3.13B
$5.95M 0.03%
334,257
– –
LUV icon
107
Southwest Airlines
LUV
$21.7B
$5.88M 0.03%
+151,290
New +$5.75M
AMGN icon
108
Amgen
AMGN
$209B
$5.77M 0.03%
34,591
-100
-0.3% -$16.9K
SBR
109
Sabine Royalty Trust
SBR
$1.06B
$5.56M 0.03%
151,249
– –
NFX
110
DELISTED
Newfield Exploration
NFX
$5.28M 0.03%
121,375
– –
EQNR icon
111
Equinor
EQNR
$97.3B
$5.04M 0.03%
299,898
-13,602
-4% -$221K
SJM icon
112
J.M. Smucker
SJM
$13.5B
$4.98M 0.03%
36,767
– –
CSCO icon
113
Cisco
CSCO
$444B
$4.79M 0.03%
151,088
– –
CAT icon
114
Caterpillar
CAT
$361B
$4.49M 0.02%
50,603
-10,355
-17% -$847K
SBUX icon
115
Starbucks
SBUX
$119B
$4.15M 0.02%
76,622
-2,480
-3% -$139K
CL icon
116
Colgate-Palmolive
CL
$74.8B
$3.83M 0.02%
51,590
-400
-0.8% -$29.6K
ALXN
117
DELISTED
Alexion Pharmaceuticals
ALXN
$3.77M 0.02%
30,756
-306,225
-91% -$39.4M
LEG icon
118
Leggett & Platt
LEG
$1.4B
$3.65M 0.02%
80,000
– –
INXN
119
DELISTED
Interxion Holding N.V.
INXN
$3.49M 0.02%
96,461
– –
OKS
120
DELISTED
Oneok Partners LP
OKS
$3.22M 0.02%
80,535
– –
BIIB icon
121
Biogen
BIIB
$30.9B
$3.04M 0.02%
9,713
– –
WPZ
122
DELISTED
Williams Partners L.P.
WPZ
$2.82M 0.02%
75,868
-3,850
-5% -$142K
DD icon
123
DuPont de Nemours
DD
$18.7B
$2.75M 0.02%
20,935
-722
-3% -$96.3K
FCX icon
124
Freeport-McMoran
FCX
$86.3B
$2.6M 0.01%
238,962
-6,500
-3% -$74.8K
T icon
125
AT&T
T
$164B
$2.41M 0.01%
78,646
-18,015
-19% -$569K
3 4
5
6 7

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
  • Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
  • Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
  • Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
  • Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.